Question
A clinical trial is run to assess the efficacy of a new drug to reduce high blood pressure. Patients with a diagnosis of hypertension (high
A clinical trial is run to assess the efficacy of a new drug to reduce high blood pressure. Patients with a diagnosis of hypertension (high blood pressure) are recruited to participate in the trial and randomized to receive either the new drug or placebo. Participants take the assigned drug for 12 weeks and their blood pressure status is recorded. At the end of the trial, participants are classified as still having hypertension or not. The data are shown here:
Group
Number Randomized
Number Free of Hypertension at 12 Weeks
Placebo
50
12
New Drug
50
28
What is the prevalence of hypertension at the end of the trial?
Group of answer choices
12%
28%
60%
50%
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started